Blog

Sixfold Bioscience joins UK biotech leaders in Parliament

July 5, 2023

LONDON, UK –  Sixfold Bioscience's co-CEO, Dr. George Foot, joins a delegation of key figures from the UK's biotech industry as part of the Bioindustry Association's (BIA) 2023 Parliament Day. The event brought together 38 biotechnology leaders and 30 senior stakeholders, including key figures from governmental departments.

Number 10 Downing Street was a particular highlight, where members of the delegation met the Secretary of State for Science, Innovation and Technology, Chloe Smith MP, and Bill Morgan, Special Adviser to the Prime Minister on Health.

Leading voices from the biotech industry have been instrumental in addressing critical policies, such as R&D tax credits and the Innovative Medicines Fund, ensuring the life science sector's voice is heard and understood at the highest levels of governance. Sixfold will continue to participate in engaging with policy makers to ensure that the UK biotech industry continues to thrive. 

For an in-depth summary of the day's events and discussions, please visit Bioindustry Association's Parliament Day 2023 blog: https://www.bioindustry.org/news-listing/parliament-day-2023-swapping-the-lab-bench-for-the-frontbench.html

About

Latest news

Press Release

Sixfold To Present at RNA Leaders Europe

February 22, 2024

Read more
Press Release

Søren Ottosen to Chair 5th RNAi-Based Therapeutics Summit

February 10, 2024

Read more
Press Release

Sixfold Bioscience to Present at SLAS 2024

February 6, 2024

Read more
Press Release

Sixfold Bioscience presents at UK Government's Office for Life Sciences

January 22, 2024

Read more